Corrina Kaut

Corrina Kaut is an experienced clinical operations professional currently serving as a Clinical Study Lead at Zymeworks Inc. since April 2022, following its acquisition by Jazz Pharmaceuticals. Previously, Corrina held positions such as Sr. Clinical Trial Manager at Faraday Pharmaceuticals, Clinical Trial Manager at Myovant Sciences, and Global Clinical Trials Leader at Genentech. Additional roles include Clinical Trials Manager at Cytokinetics and Clinical Site Manager at Rigel Pharmaceuticals. Corrina's early career involved drug safety roles at Nektar Therapeutics and Genentech. Educational credentials include a Clinical Trials Design and Management Certificate and a Regulatory Affairs Certificate from the University of California at Santa Cruz, as well as a BS in Occupational Therapy from San Jose State University.